BIO vs TXG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 10, 2026
BIO
TXG
Investment Advisor Scores
TXG
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BIO | TXG | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 37.594 | 769.2308 | BIO |
| PEG Ratio | 4.0063 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -0.1% | -2.6% | BIO |
| Earnings Growth | 18.7% | 0.0% | BIO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 39.6/100 | 36.0/100 | BIO |
| Profit Margin | 8.6% | -3.5% | BIO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | SELL | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BIO
MarkupPrice above SMA50, rising 50-day trend (8.1% over 20 days), RSI 81
TXG
MarkupPrice above SMA50, rising 50-day trend (31.8% over 20 days), RSI 71
Fundamentals Snapshot
| Metric | BIO | TXG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 38.9 | 318.4 |
| Trailing P/E | 46.3 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.1% |
| Gross Margin | 0.5% | 0.7% |
| Operating Margin | 0.1% | -0.2% |
| EPS | 8.25 | -0.58 |
| Dividend Yield | — | — |